Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations.
Sign Up to like & getrecommendations! Published in 2020 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.10.067
Abstract: Vaccination is the primary strategy to prevent hepatitis B virus (HBV) infection in the United States. Prior to 2017, most standard hepatitis B vaccine schedules required 3 doses over 6 months. Heplisav-B, approved in 2017, is… read more here.
Keywords: vaccination; vaccine; cost; cost utility ... See more keywords